Longevity Health Holdings Inc. Delisted from Nasdaq, Moves to OTC Markets Following Rule Violation
Longevity Health Holdings Inc., a Delaware-based corporation, announced that it received a notice from the Nasdaq Stock Market LLC on September 10, 2025, regarding a failure to meet Nasdaq Listing Rule 5550(b)(2). Consequently, the Nasdaq Panel has decided to delist the company's securities from the Nasdaq Capital Market, effective at the start of trading on September 12, 2025. Following this decision, the company's common stock and warrants will be traded on the over-the-counter markets operated by OTC Markets Group, Inc. Despite this transition, Longevity Health Holdings intends to maintain its operations and continue filing reports as required by the Securities Exchange Act of 1934. The company also remains committed to pursuing a merger with True Health Inc. and relisting the merged entity's securities on Nasdaq.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-114421), on September 12, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。